PTX 0.00% 4.0¢ prescient therapeutics limited

Cornhulio, following link on current proceedings. December 7,...

  1. 1,075 Posts.
    lightbulb Created with Sketch. 43
    Cornhulio, following link on current proceedings.
    December 7, 2016 - UC Davis to Conduct Phase 2 Trial of the Combination of TG4010 with Opdivo® (nivolumab) for 2nd Line Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC) / The trial will be supported by Transgene and Bristol-Myers Squibb http://www.transgene.fr/wp-content/...7-Collaboration_UC_Davis_Transgene-BMS_EN.pdf
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.0¢
Change
0.000(0.00%)
Mkt cap ! $32.21M
Open High Low Value Volume
4.0¢ 4.1¢ 4.0¢ $22.35K 558.4K

Buyers (Bids)

No. Vol. Price($)
6 221774 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.1¢ 860576 3
View Market Depth
Last trade - 14.51pm 19/11/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.